SEC Form D filing

Tempest Therapeutics, Inc.

Biotech · Series A · Regulation D 506(b) · CA · Filed June 23, 2026

Offering amount: $4.1M
Exemption: Reg D 506(b)
Issuer state: CA
Filing date: June 23, 2026
Signature date: June 22, 2026
CIK: 0001544227

Summary

Auto-generated

Tempest Therapeutics, Inc. is a biotechnology company focused on developing targeted oncology therapies. It filed a Rule 506(b) offering for approximately $4.06 million on June 23, 2026.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.